Deva Holding AS | DEVA - Aktiva

Harga Saham

64.35

Perubahan Harian

-2.05 -3.09%

Bulanan

-14.82%

Tahunan

-10.63%

Q1 Perkiraan

63.61

Keuangan

TRY

TRY 12.93B

TRY 775.92M

Biaya Penjualan

TRY 991.13M

TRY 9.13B

Kewajiban Lancar

TRY 6.43B

TRY 5.3B

Dividen - Hasil

0.18

TRY 820.88M

TRY 882.9M

Eps Laba Per Saham

TRY 2.92

Modal Dan Cadangan

TRY 5.79B

Laba Kotor Pada Penjualan

TRY 1.32B

Beban Bunga Utang

TRY 272.53M

TRY 559.97M

Kapitalisasi Pasar

TRY 12.87B

Batas Pemasukan

TRY 583.98M

Biaya Operasional

TRY 1.35B

Laba Operasional

TRY 964.87M

Modal Saham Biasa

TRY 200.02M

Pe Harga Untuk Laba

6.55

Pendapatan Penjualan

TRY 2.32B

Beban Penjualan Dan Administrasi

TRY 462.26M

Kreditur Perdagangan

TRY 809.81M

Debitur Perdagangan

TRY 3.03B

	Aktiva	Perubahan		Tanggal
Akebia Therapeutics	USD 376.56M		12.41M	2025-12
Alaunos Therapeutics	USD 3.72M		1.01M	2025-09
Avita Medical	AUD 56.39M		1.74M	2025-12
Deva Holding AS	TRY 12.93B		1.83B	2023-09
Dianthus Therapeutics	USD 530.92M		46.52M	2025-12
Ionis Pharmaceuticals	USD 3.52B		490.91M	2025-12
IQVIA Holdings	USD 29.94B		1.22B	2025-12
Moderna	USD 12.34B		203M	2025-12
Organon & Co	USD 13.55B		52M	2025-09
Revvity	USD 12.17B		29.46M	2025-12
Tectonic Therapeutic	USD 277M		18.31M	2025-09
Viatris	USD 37.19B		727.3M	2025-12
Xeris Pharmaceuticals	USD 370.19M		35.5M	2025-09